Patents by Inventor Mark D. Fidock

Mark D. Fidock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enzyme PDE XVI
    Patent number: 7091024
    Abstract: Amino acid sequences and nucleotide sequences relating to PDE_XIV are described. In a preferred aspect, the amino acid sequences comprise the sequence presented as SEQ ID NO:1 or SEQ ID NO:3 or SEQ ID NO:5.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: August 15, 2006
    Assignee: Pfizer Inc.
    Inventor: Mark D. Fidock
  • Phosphodiesterase enzymes
    Patent number: 7063971
    Abstract: Amino acid sequences and nucleotide sequences relating to PDEXV are described. In a preferred aspect, the amino acid sequence comprises the sequence presented as SEQ ID NO:1.
    Type: Grant
    Filed: December 24, 2003
    Date of Patent: June 20, 2006
    Assignee: Pfizer Inc.
    Inventors: Mark D. Fidock, Nicola M. Robas
  • Phosphodiesterase enzymes
    Patent number: 7052895
    Abstract: Amino acid sequences and nucleotide sequences relating to PDE1B2 are described. In a preferred aspect, the amino acid sequence comprises the sequence presented as SEQ ID No. 1.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: May 30, 2006
    Assignee: Pfizer Inc.
    Inventor: Mark D. Fidock
  • Enzyme PDE XVI
    Publication number: 20040137508
    Abstract: Amino acid sequences and nucleotide sequences relating to PDE_XIV are described. In a preferred aspect, the amino acid sequences comprise the sequence presented as SEQ ID NO:1 or SEQ ID NO:3 or SEQ ID NO:5.
    Type: Application
    Filed: February 18, 2004
    Publication date: July 15, 2004
    Applicant: Pfizer Inc.
    Inventor: Mark D. Fidock
  • Phosphodiesterase enzymes
    Publication number: 20040126863
    Abstract: Amino acid sequences and nucleotide sequences relating to PDEXV are described. In a preferred aspect, the amino acid sequence comprises the sequence presented as SEQ ID NO:1.
    Type: Application
    Filed: December 24, 2003
    Publication date: July 1, 2004
    Applicant: Pfizer Inc
    Inventors: Mark D. Fidock, Nicola M. Robas
  • Neuropeptide receptor and uses thereof
    Publication number: 20030104487
    Abstract: This invention relates to the identification of an orphan G-protein coupled receptor EBI2 (and variants thereof) as a receptor of neuropeptides of the CRF family, and the use of such peptides, e.g. urotensin I or sauvagine (and analogues or mimetics of either one) as modulators for EBI2. It also relates to screening methods to identify agonists and antagonists for this neuropeptide receptor.
    Type: Application
    Filed: August 15, 2002
    Publication date: June 5, 2003
    Inventors: Mark D. Fidock, Nicola M. Robas